OAM
AMRX icon

OP Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

OP Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Sell
17,667
-75,988
-81% -$1.02M ﹤0.01% 725
2025
Q4 		$1.18M Sell
93,655
-61,128
-39% -$699K 0.01% 564
2025
Q3 		$1.55M Buy
154,783
+105,252
+212% +$945K 0.02% 513
2025
Q2 		$401K Hold
49,531
– – 0.01% 696
2025
Q1 		$415K Buy
+49,531
New +$413K 0.01% 703

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OP Asset Management's AMRX Position: Q1 2026 in Review

OP Asset Management reduced its Amneal Pharmaceuticals (AMRX) stake by 81% in Q1 2026, selling an estimated $1.02M and leaving 17,667 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

OP Asset Management first reported a position in AMRX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.55M in Q3 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • OP Asset Management held 17,667 shares of Amneal Pharmaceuticals worth $220K as of Q1 2026.
  • OP Asset Management sold 75,988 Amneal Pharmaceuticals shares in Q1 2026, an estimated $1.02M.
  • Amneal Pharmaceuticals made up ﹤0.01% of OP Asset Management's portfolio in Q1 2026, its #725 holding.
  • OP Asset Management first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • OP Asset Management's Amneal Pharmaceuticals position peaked at $1.55M in Q3 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.